You are here

ocedurenone

Novo's kidney disease drug fails to improve blood pressure in phase 3, spurring $816M loss

Fierce Biotech

Thu, 06/27/24 - 11:38 am

clinical trials

Novo Nordisk, with coffers filling with cash, buys rival to Bayer's kidney drug Kerendia in $1.3B deal

Fierce Biotech

Mon, 10/16/23 - 10:24 am

KBP Biosciences

chronic kidney disease